Article Information
- Received November 5, 2008
- Accepted May 13, 2009
- Published online January 1, 2009.
Author Information
- Thomas J. Errico, MDa,
Dr. Thomas Errico will receive royalties from Stryker Corp.; owns stock in K2M, Inc. and Stryker Corp.; consults for Stryker Corp. and Fastenetix, LLC; has received research support from Synthes, Inc., Paradigm Spine, LLC, and Stryker Corp.; and has received support of clinical staff or training from Medtronic, DePuy Spine, Synthes, Inc., and Paradigm Spine, LLC.
- Jonathan R. Kamerlink, MDa,
Dr. Jonathan Kamerlink has received travel expenses from Paradigm Spine, LLC.
- Martin Quirno, MDa,
Dr. Martin Quirno has received travel expenses from Stryker Corp. and Paradigm Spine, LLC.
- Jacques Samani, MDband
Dr. Jacques Samani has received royalties from, owns stock in, has consulted for, has received speaking arrangements from, is on the Scientific Advisory Board for, and has received travel expenses from Paradigm Spine, LLC.
- Robert J. Chomiak, MSc
Robert Chomiak is an employee of, owns stock in, and has received travel expenses from Paradigm Spine, LLC.
- aNYU-Hospital for Joint Diseases, New York, New York USA
- bChirurgie Orthopedique, Lyon, France
- cParadigm Spine, LLC, New York, New York USA
- Address correspondence to Dr. Thomas J. Errico, MD, Chief, Division of Spine Surgery, Department of Orthopaedic Surgery, NYU Medical Center, 530 First Avenue, Suite 8U, New York, NY 10016. (email: spinecore{at}hotmail.com)